XML 36 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Net Sales
 12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Net Sales

15. Net Sales

Disaggregated Net Sales

As discussed in Note 1, we primarily derive our revenues from the sales of various chemical products. The following table presents our net sales disaggregated by our principal markets, which disaggregation is consistent with other financial information utilized or provided outside of our consolidated financial statements:

 

 

 

 

 

 

 

2022

 

 

2021

 

 

2020

 

 

 

(In Thousands)

 

Net sales:

 

 

 

 

 

 

 

 

 

AN & Nitric Acid

 

$

315,679

 

 

$

228,754

 

 

$

150,902

 

Urea ammonium nitrate (UAN)

 

 

239,463

 

 

 

123,840

 

 

 

75,031

 

Ammonia

 

 

284,005

 

 

 

155,159

 

 

 

84,222

 

Other

 

 

62,564

 

 

 

48,486

 

 

 

41,161

 

Total net sales

 

$

901,711

 

 

$

556,239

 

 

$

351,316

 

 

Other Information

Although most of our contracts have an original expected duration of one year or less, for our contracts with a duration greater than one year at contract inception, the average remaining expected duration was approximately 29 months at December 31, 2022.

Liabilities associated with contracts with customers (contract liabilities) primarily relate to deferred revenue and customer deposits associated with cash payments received in advance from customers for volume shortfall charges and product shipments. We had approximately $2.0 million and $1.6 million of contract liabilities as of December 31, 2022 and 2021, respectively. During 2022 and 2021, revenues of $1.5 million and $2.5 million, respectively were recognized and included in the balance at the beginning of the period.

At December 31, 2022, we have remaining performance obligations with certain customer contracts, excluding contracts with original durations of less than one year and contracts with variable consideration for which we have elected the practical expedient for consideration recognized in revenue as invoiced. The remaining performance obligations total approximately $100 million, of which approximately 63% of this amount relates to 2023 through 2025, approximately 24% relates to 2026 through 2027, with the remainder thereafter.